![Patrick Campbell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick Campbell
Direttore Tecnico/Scientifico/R&S presso Augmenix, Inc.
Profilo
Patrick Campbell currently works as a Chief Technology Officer & Director at Augmenix, Inc.
Posizioni attive di Patrick Campbell
Società | Posizione | Inizio |
---|---|---|
Augmenix, Inc.
![]() Augmenix, Inc. Medical SpecialtiesHealth Technology Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Augmenix, Inc.
![]() Augmenix, Inc. Medical SpecialtiesHealth Technology Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA. | Health Technology |
- Borsa valori
- Insiders
- Patrick Campbell